Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection

Clinical trial NCT01001754 · UNKNOWN

Trial details

NCT number: NCT01001754
Sponsor: ZymoGenetics
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2010-05-01
Primary completion: 2010-11-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.